Neuland Laboratories Limited (NSE: NEULANDLAB)

Market Cap	169.30B
Revenue (ttm)	15.28B
Net Income (ttm)	2.80B
Shares Out	n/a
EPS (ttm)	217.98
PE Ratio	60.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 12, 2024

Volume	37,071
Average Volume	30,447
Open	13,751
Previous Close	13,222
Day's Range	13,314 - 13,959
52-Week Range	5,425 - 18,100
Beta	0.98
RSI	46.97
Earnings Date	Feb 4, 2025

About Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 1,643
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NEULANDLAB

Financial Performance

In 2023, Neuland Laboratories's revenue was 15.59 billion, an increase of 30.81% compared to the previous year's 11.91 billion. Earnings were 3.00 billion, an increase of 83.51%.